SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
FibroGen, Inc.’s FG-3019 Granted U.S. Orphan Drug Designation for the Treatment of Patients With Idiopathic Pulmonary Fibrosis